Big Gain For Bellicum Pharmaceuticals, Inc.
Fri, Sep 22, 2023 at 07:29 PM
Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ) shot up at $0.48, a gain of 29%. On Fri, Sep 22, 2023, BLCM:NASDAQ touched a New 2-Week High of $0.48. From Fri, Sep 08, 2023, the stock recorded 70.00% Up Days and 72.73% Green Days
The stock spiked on Mon, May 08, 2023 at $1.31 with a volume of 100M+.
About Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ)
Bellicum Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The firm is primarily engaged in the research of cellular immunotherapies for hematological cancers, solid tumors, and orphan inherited blood diseases.
Top 10 Gainers:
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Lifezone Metals Limited (LZM:NYSE), 37.5%
- Cheche Group Inc. (CCG:NASDAQ), 31.45%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 29.01%
- Ohmyhome Limited (OMH:NASDAQ), 28.86%
- Mondee Holdings Inc. (MOND:NASDAQ), 25.86%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 22.15%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 21.83%
- Etao International Co. Ltd. (ETAO:NASDAQ), 20.34%
- Warrantee Inc. (WRNT:NASDAQ), 19.96%